Emerging peptide nanomedicine to regenerate tissues and organs

M. J. Webber, J. A. Kessler, Samuel I Stupp

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Peptide nanostructures containing bioactive signals offer exciting novel therapies of broad potential impact in regenerative medicine. These nanostructures can be designed through self-assembly strategies and supramolecular chemistry, and have the potential to combine bioactivity for multiple targets with biocompatibility. It is also possible to multiplex their functions by using them to deliver proteins, nucleic acids, drugs and cells. In this review, we illustrate progress made in this new field by our group and others using peptide-based nanotechnology. Specifically, we highlight the use of self-assembling peptide amphiphiles towards applications in the regeneration of the central nervous system, vasculature and hard tissue along with the transplant of islets and the controlled release of nitric oxide to prevent neointimal hyperplasia. Also, we discuss other self-assembling oligopeptide technology and the progress made with these materials towards the development of potential therapies.

Original languageEnglish
Pages (from-to)71-88
Number of pages18
JournalJournal of Internal Medicine
Volume267
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Nanomedicine
Nanostructures
Peptides
Oligopeptides
Nanotechnology
Regenerative Medicine
Nucleic Acids
Hyperplasia
Regeneration
Nitric Oxide
Central Nervous System
Technology
Transplants
Therapeutics
Pharmaceutical Preparations
Proteins

Keywords

  • Bioactive nanostructures
  • Peptide amphiphiles
  • Regenerative medicine
  • Self-assembly

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Emerging peptide nanomedicine to regenerate tissues and organs. / Webber, M. J.; Kessler, J. A.; Stupp, Samuel I.

In: Journal of Internal Medicine, Vol. 267, No. 1, 01.2010, p. 71-88.

Research output: Contribution to journalArticle

Webber, M. J. ; Kessler, J. A. ; Stupp, Samuel I. / Emerging peptide nanomedicine to regenerate tissues and organs. In: Journal of Internal Medicine. 2010 ; Vol. 267, No. 1. pp. 71-88.
@article{11f5806dba104bef82c23ec6bd6011fe,
title = "Emerging peptide nanomedicine to regenerate tissues and organs",
abstract = "Peptide nanostructures containing bioactive signals offer exciting novel therapies of broad potential impact in regenerative medicine. These nanostructures can be designed through self-assembly strategies and supramolecular chemistry, and have the potential to combine bioactivity for multiple targets with biocompatibility. It is also possible to multiplex their functions by using them to deliver proteins, nucleic acids, drugs and cells. In this review, we illustrate progress made in this new field by our group and others using peptide-based nanotechnology. Specifically, we highlight the use of self-assembling peptide amphiphiles towards applications in the regeneration of the central nervous system, vasculature and hard tissue along with the transplant of islets and the controlled release of nitric oxide to prevent neointimal hyperplasia. Also, we discuss other self-assembling oligopeptide technology and the progress made with these materials towards the development of potential therapies.",
keywords = "Bioactive nanostructures, Peptide amphiphiles, Regenerative medicine, Self-assembly",
author = "Webber, {M. J.} and Kessler, {J. A.} and Stupp, {Samuel I}",
year = "2010",
month = "1",
doi = "10.1111/j.1365-2796.2009.02184.x",
language = "English",
volume = "267",
pages = "71--88",
journal = "Journal of Internal Medicine",
issn = "0954-6820",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Emerging peptide nanomedicine to regenerate tissues and organs

AU - Webber, M. J.

AU - Kessler, J. A.

AU - Stupp, Samuel I

PY - 2010/1

Y1 - 2010/1

N2 - Peptide nanostructures containing bioactive signals offer exciting novel therapies of broad potential impact in regenerative medicine. These nanostructures can be designed through self-assembly strategies and supramolecular chemistry, and have the potential to combine bioactivity for multiple targets with biocompatibility. It is also possible to multiplex their functions by using them to deliver proteins, nucleic acids, drugs and cells. In this review, we illustrate progress made in this new field by our group and others using peptide-based nanotechnology. Specifically, we highlight the use of self-assembling peptide amphiphiles towards applications in the regeneration of the central nervous system, vasculature and hard tissue along with the transplant of islets and the controlled release of nitric oxide to prevent neointimal hyperplasia. Also, we discuss other self-assembling oligopeptide technology and the progress made with these materials towards the development of potential therapies.

AB - Peptide nanostructures containing bioactive signals offer exciting novel therapies of broad potential impact in regenerative medicine. These nanostructures can be designed through self-assembly strategies and supramolecular chemistry, and have the potential to combine bioactivity for multiple targets with biocompatibility. It is also possible to multiplex their functions by using them to deliver proteins, nucleic acids, drugs and cells. In this review, we illustrate progress made in this new field by our group and others using peptide-based nanotechnology. Specifically, we highlight the use of self-assembling peptide amphiphiles towards applications in the regeneration of the central nervous system, vasculature and hard tissue along with the transplant of islets and the controlled release of nitric oxide to prevent neointimal hyperplasia. Also, we discuss other self-assembling oligopeptide technology and the progress made with these materials towards the development of potential therapies.

KW - Bioactive nanostructures

KW - Peptide amphiphiles

KW - Regenerative medicine

KW - Self-assembly

UR - http://www.scopus.com/inward/record.url?scp=71949095402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949095402&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2796.2009.02184.x

DO - 10.1111/j.1365-2796.2009.02184.x

M3 - Article

C2 - 20059645

AN - SCOPUS:71949095402

VL - 267

SP - 71

EP - 88

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

SN - 0954-6820

IS - 1

ER -